151 related articles for article (PubMed ID: 32340482)
1. Temporal Trends and Practice Patterns for Inpatient Management of Malignant Extrinsic Ureteral Obstruction in the United States.
Haas CR; Shah O; Hyams ES
J Endourol; 2020 Aug; 34(8):828-835. PubMed ID: 32340482
[No Abstract] [Full Text] [Related]
2. Stent failure in the management of malignant extrinsic ureteral obstruction: risk factors.
Kamiyama Y; Matsuura S; Kato M; Abe Y; Takyu S; Yoshikawa K; Arai Y
Int J Urol; 2011 May; 18(5):379-82. PubMed ID: 21518020
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous nephrostomy vs ureteral stent for hydronephrosis secondary to ureteric calculi: impact on spontaneous stone passage and health-related quality of life-a prospective study.
de Sousa Morais N; Pereira JP; Mota P; Carvalho-Dias E; Torres JN; Lima E
Urolithiasis; 2019 Dec; 47(6):567-573. PubMed ID: 30219938
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
5. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
Matsuura H; Arase S; Hori Y
Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
[TBL] [Abstract][Full Text] [Related]
6. Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer.
Tan S; Tao Z; Bian X; Zhao Y; Wang N; Chen X; Wu B
Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():99-103. PubMed ID: 31484100
[TBL] [Abstract][Full Text] [Related]
7. Predicting the success of retrograde stenting for managing ureteral obstruction.
Yossepowitch O; Lifshitz DA; Dekel Y; Gross M; Keidar DM; Neuman M; Livne PM; Baniel J
J Urol; 2001 Nov; 166(5):1746-9. PubMed ID: 11586215
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.
Song Y; Fei X; Song Y
Int J Gynecol Cancer; 2012 May; 22(4):697-702. PubMed ID: 22315095
[TBL] [Abstract][Full Text] [Related]
9. The management of malignant ureteral obstruction treated with ureteral stents.
Ganatra AM; Loughlin KR
J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
[TBL] [Abstract][Full Text] [Related]
10. Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.
Kim SH; Park B; Joo J; Joung JY; Seo HK; Chung J; Lee KH
PLoS One; 2017; 12(9):e0184965. PubMed ID: 28931043
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer.
Spencer BA; Insel BJ; Hershman DL; Benson MC; Neugut AI
Support Care Cancer; 2013 May; 21(5):1303-11. PubMed ID: 23292697
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcomes of Double-Layered Polytetrafluoroethylene Membrane-Covered Self-Expandable Segmental Metallic Stents (Uventa) in Patients with Chronic Ureteral Obstructions: Is It Really Safe?
Kim M; Hong B; Park HK
J Endourol; 2016 Dec; 30(12):1339-1346. PubMed ID: 27736158
[TBL] [Abstract][Full Text] [Related]
13. Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study.
ElSheemy MS; Shouman AM; Shoukry AI; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA; Badawy H
BJU Int; 2015 Mar; 115(3):473-9. PubMed ID: 24698195
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Outcomes of Malignant Ureteral Obstruction Secondary to Ovarian Cancer: Predictors of Resolution and the Role of Surgical Management.
Faidley KN; Botkin HE; Loeffler BT; Mott SL; Hansen SC; Hill EK; Erickson BA
Urology; 2024 Apr; 186():101-106. PubMed ID: 38350551
[TBL] [Abstract][Full Text] [Related]
15. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
[TBL] [Abstract][Full Text] [Related]
16. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.
Chung SY; Stein RJ; Landsittel D; Davies BJ; Cuellar DC; Hrebinko RL; Tarin T; Averch TD
J Urol; 2004 Aug; 172(2):592-5. PubMed ID: 15247739
[TBL] [Abstract][Full Text] [Related]
17. Management of extrinsic malignant ureteral obstruction with urinary diversion.
Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
[TBL] [Abstract][Full Text] [Related]
18. Management of acute hydronephrosis in pregnancy by ureteral stenting.
Zwergel T; Lindenmeir T; Wullich B
Eur Urol; 1996; 29(3):292-7. PubMed ID: 8740034
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous nephrostomy versus indwelling ureteral stents in patients with bilateral nongenitourinary malignant extrinsic obstruction.
Park DS; Park JH; Lee YT
J Endourol; 2002 Apr; 16(3):153-4. PubMed ID: 12028623
[TBL] [Abstract][Full Text] [Related]
20. Likelihood of retrograde double-J stenting according to ureteral obstructing pathology.
Danilovic A; Antonopoulos IM; Mesquita JL; Lucon AM
Int Braz J Urol; 2005; 31(5):431-6; discussion 436. PubMed ID: 16255788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
